Live
- Youth dies by suicide on moving APSRTC bus
- Don’t harass students for fees: Collector
- K’taka HC dismisses interim application of Subbareddy
- Will keep our promise of developing Channapatna: DCM
- Don’t collect excess fee from students
- Double registration leads to enmity between two parties
- JD(S) first family avoids discussion on bypoll debacle
- Hari Chandana’s Green Initiatives: Transforming Hyderabad for a better Future
- Gangavati railway station to be renamed Anjanadri: MB Patil
- Bhool Bhulaiyaa 3 Continues to Dominate the Box Office, Grossing Rs 247 Crore
Granules India arm gets USFDA nod for an antiviral
Highlights
Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.
Hyderabad: Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.
"The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a-wholly owned foreign subsidiary of Granules India Ltd for Valganciclovir hydrochloride for oral solution, 50 mg/ml," the company said in a regulatory filing.
Next Story
ADVERTISEMENT
